Jiangxi Synergy Pharmaceutical Co., Ltd.
               Home                       About us                             Products                        Order                      QC/QA                       R&D                         News                        Contact us                中文版
API
   Gabapentin
   Rebamipide
   Venlafaxine HCI
   Aceclofenac
   Candesartan Cilexetil
   Telmisartan
   Miltefosine
Intermediates
   4-Bromomethyl-2(1H)-quinolinone
    2-Amino-3[2(1H)-quinolinon-4-yl] - Propionic acid•2HCI•2H20
   1-[2-Amino-1-(4-Methoxyphenyl) ethyl] Cyclohexanol•HCI
   Trityl Candesartan Cilexetil
   Trityl Candesartan
   Candesartan
   Methyl 1-[ (2’-cyanobiphenyl-4-yl) methyl] -2-ethoxy-1H-benzimidazole-7-carboxylate
   Methyl-2-ethoxy-1H- benzimidazole -7-carboxylate
   6-Methoxy-1-Tetralone
   7-Methoxy-1-Tetralone
   2-{[(4- chloro -3- methyl -2 pyridinyl) methyl] thio }1H benzimidazole
 
 

  News

A year-end summary & appraisal general assembly of Jiangxi Synergy Pharma Ltd has been held on Febuary 10, 2010. Seventeen excellent staff such as Shen Lihua, Liang Meng have been awarded as advanced workers or working activists in 2009.
In company senior staff conference on January 5, 2010, Jiangxi Synergy Pharma Ltd has officially determined that the turnover in the coming 2010 should be double as that of 2009.
GMP Certificate of Venlafaxine HCL has been issued to Jiangxi Synergy Pharma Ltd by SFDA on December 24, 2009, with Certificate No of Gan K0330.
In 2009, Jiangxi Synergy Pharma Ltd has totally received 52 times of on-site audit and visit with the customers from the United States, Canada, Japan, France, Spain, Italy, Korea and so on.
Jiangxi Synergy Pharma Ltd has passed on-site GMP audit by SFDA regarding to the product Venlafaxine HCL on November 6, 2009.
October 13-15, 2009
Jiangxi Synergy Pharma Ltd. will participate in CPHI exhibition in Madrid, our booth is 7E60.
The EHS system of Jiangxi Synergy Pharma Ltd has passed on-site audit by US Pfizer on October27, 2009.
September 25-28, 2009
To celebrate the 60th anniversary of P.R.C, labor union of Jiangxi Synergy Pharma Ltd organized staff from workshops and administrative office to take part in various sportive activities such as basketball, table tennis, tug-of-war, fishing and playing card.
September 6-11, 2009
The Center for Drug Evaluation and Research/ Division of Manufacturing and Product
Quality (CDER/DMPQ), which operates under the U.S Food and Drug Administration
(FDA), conducted a 5-day on-site inspection to Jiangxi Synergy Pharma Ltd. The
cGMP inspection evaluated items including the quality system, facilities, storage,
manufacturing, packaging and labeling, and laboratories. Finally the U.S FDA officer
issued 483 form with only two minor observations.
During the overall inspection on manufacturing safety conducted by authority in September 2009, the EHS performance of Jiangxi Synergy Pharma Ltd got a favorable reception from concerned authority of county.

 

 
  ADD: Jiangxi Fengxin Industrial Park, Fengxin,Jiangxi 330700,P.R.China
Tel: +86-795- 4605771,4605608
Fax: +86-795-4605772
E-mail: info@jxsynergy.com
Copyright(C)2009,Jiangxi Synergy Pharmaceutical Co., Ltd. All Rights Reserved.  
Supported by
 ChemNet ChinaChemNet Toocle
 
Corporate culture Manufacture facilities Warehouse Facilities